Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04935775 · ClinicalTrials.gov registry record · NA

The Effect of Touch on Pain and Anxiety During the Bone Marrow Biopsy Procedure

A NA study of Anxiety and Pain, Acute, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT04935775: Completed NA study of Anxiety and Pain, Acute, sponsored by Dartmouth-Hitchcock Medical Center.

NCT04935775 is a NA study of Anxiety and Pain, Acute that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 46 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04935775, a NA study of Anxiety and Pain, Acute, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

This study is analyzing the benefit of untrained touch provided during a bone marrow biopsy procedure as compared to performing the procedure without providing it.

Primary Outcome

Patients be asked to describe what their pain level was before, at its worst point during the procedure and after the bone marrow biopsy. The Visual Analog Scale (VAS) will be used on a 0 to 10 scale, 0 being no pain at all and 10 being the worst pain imaginable.

Conditions Studied

Interventions

  • OTHER Untrained Touch

Study Locations (1)

New Hampshire

  • Dartmouth Hitchcock Medical Center, Dartmouth Cancer Center - Lebanon

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2021-10-13
Est. Completion 2022-04-20
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT04935775 record still lists

NCT04935775 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (90% lower).

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Untrained Touch is the first listed.

NCT04935775 reports a single indexed study location in New Hampshire.

Frequently Asked Questions

What is clinical trial NCT04935775 about?

NCT04935775 is a clinical study titled "The Effect of Touch on Pain and Anxiety During the Bone Marrow Biopsy Procedure". This study is analyzing the benefit of untrained touch provided during a bone marrow biopsy procedure as compared to performing the procedure without providing it.

What is the current status of trial NCT04935775?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2021-10-13. Estimated completion is 2022-04-20.

What conditions does trial NCT04935775 study?

This clinical trial studies the following conditions: Anxiety, Pain, Acute.

What interventions are being tested in trial NCT04935775?

The interventions under investigation include: Untrained Touch (OTHER).

Who is sponsoring clinical trial NCT04935775?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04935775 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04935775's enrollment target sits among peer trials

46 258th of 364 higher than 107 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04935775, the US trial registry maintained by the National Library of Medicine. NCT04935775 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.